ArticleFrontiers in immunology2023

Transarterial chemoembolization combined with molecularly targeted agents plus immune checkpoint inhibitors for unresectable hepatocellular carcinoma: a retrospective cohort study.

Nan Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.